Pallabi Basu

Pallabi Basu

Auto-generated profile, based on publicly available information

Pallabi Basu

Division of Infectious Diseases, Boston Children’s Hospital

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
MGMichael J. Gebhardt
Michael J. Gebhardt
EFElizabeth A. Farland
Elizabeth A. Farland
PBPallabi Basu
Pallabi Basu
KMKeven Macareno
Keven Macareno
SMSahar Melamed
Sahar Melamed
SDSimon L. Dove
Simon L. Dove
The RNA chaperone Hfq plays important regulatory roles in many bacteria by facilitating the base pairing between small RNAs (sRNAs) and their cognate mRNA targets. In the gram-negative opportunistic pathogen Pseudomonas aeruginosa , over a hundred putative sRNAs have been identified but for most, their regulatory targets remained unknown. Using RIL-seq with Hfq in P. aeruginosa , we identified the mRNA targets for dozens of previously known and unknown sRNAs. Strikingly, hundreds of the RNA–RNA interactions we discovered involved PhrS. This sRNA was thought to mediate its effects by pairing with a single target mRNA and regulating the abundance of the transcription regulator MvfR required for the synthesis of the quorum sensing signal PQS. We present evidence that PhrS controls many transcripts by pairing with them directly and employs a two-tiered mechanism for governing PQS synthesis that involves control of an additional transcription regulator called AntR. Our findings in P. aeruginosa expand the repertoire of targets for previously known sRNAs, reveal potential regulatory targets for previously unknown sRNAs, and suggest that PhrS may be a keystone sRNA with the ability to pair with an unusually large number of transcripts in this organism.

21 April 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
PBPallabi Basu
Pallabi Basu
MEMaya Elgrably-Weiss
Maya Elgrably-Weiss
FHFouad Hassouna
Fouad Hassouna
MKManoj Kumar
Manoj Kumar
RWReuven Wiener
Reuven Wiener
SAShoshy Altuvia
Shoshy Altuvia
The RNA chaperone Hfq, acting as a hexamer, is a known mediator of post-transcriptional regulation, expediting basepairing between small RNAs (sRNAs) and their target mRNAs. However, the intricate details associated with Hfq-RNA biogenesis are still unclear. Previously, we reported that the stringent response regulator, RelA, is a functional partner of Hfq that facilitates Hfq-mediated sRNA–mRNA regulation in vivo and induces Hfq hexamerization in vitro. Here we show that RelA-mediated Hfq hexamerization requires an initial binding of RNA, preferably sRNA to Hfq monomers. By interacting with a Shine–Dalgarno-like sequence (GGAG) in the sRNA, RelA stabilizes the initially unstable complex of RNA bound-Hfq monomer, enabling the attachment of more Hfq subunits to form a functional hexamer. Overall, our study showing that RNA binding to Hfq monomers is at the heart of RelA-mediated Hfq hexamerization, challenges the previous concept that only Hfq hexamers can bind RNA.

16 January 2026 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PBPallabi Basu
Pallabi Basu
EFElizabeth A. Farland
Elizabeth A. Farland
JCJames C. Charity
James C. Charity
KTKade A. Townsend
Kade A. Townsend
SDSimon L. Dove
Simon L. Dove
Bacterial RNA-binding proteins (RBPs) that control the translation of multiple transcripts act largely as negative regulators. Here, we report the identification and characterization of a positive regulator of translation (called PhaF) in the opportunistic pathogen Pseudomonas aeruginosa . Using CLIP-seq and CLAP-seq we identify upward of 50 transcripts targeted by PhaF. We demonstrate that PhaF acts to stimulate the translation of target mRNAs by binding upstream of the Shine–Dalgarno sequence using one or more of the multiple KPAA motifs located in an intrinsically disordered region of the protein. Importantly, we show that PhaF plays a key physiological role in P. aeruginosa through its translational control of the pslA transcript required for exopolysaccharide synthesis and biofilm formation. Our findings uncover an activator of translation in bacteria that binds target transcripts using an RNA-binding region reminiscent of those that are prominent in eukaryotic RBPs.

18 March 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
JFJamal Fahoum
Jamal Fahoum
MBMaria Billan
Maria Billan
JVJulia K Varga
Julia K Varga
DPDan Padawer
Dan Padawer
MEMaya Elgrably-Weiss
Maya Elgrably-Weiss
ARAlexander Rouvinski
Alexander Rouvinski
SARS-CoV-2 infection triggers strong antibody response toward Nucleocapsid-Protein (NP), suggesting extracellular presence beyond its intra-virion RNA binding. Interestingly, NP was found to decorate infected and proximal uninfected cell-surfaces. Here, we propose a new mechanism through which extracellular NP on uninfected cells contributes to COVID-19 pathogenicity. We show that NP binds to cell-surface sulfated linear-glycosaminoglycans by spatial rearrangement of its RNA-binding sites facilitated by the flexible, positively charged, linker. Coating of uninfected lung-derived cells with purified NP attracted anti-NP-IgG from lung fluids and sera collected from COVID-19 patients. The magnitude of this immune recognition was significantly elevated in moderate compared to mild COVID-19 cases. Importantly, binding of anti-NP-IgG present in sera generated clusters that triggered C3b deposition by the classical complement pathway. Heparin analog enoxaparin outcompeted NP-binding, rescuing cells from anti-NP IgG-mediated complement deposition. Our findings unveil how extracellular NP may exacerbate COVID-19 tissue damage, and suggest leads for preventative therapy. Highlights IgG from patients’ sera target NP-bound cells resulting in complement activation The flexible linker allows NP to both bind linear sulfated GAGs and wrap around RNA Heparin analogs prevent NP surface binding and alleviate complement activation Cell-ELISA anti-NP IgG levels differ between mild and moderate COVID-19

10 September 2026 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
RSRenato E. R. S. Santos
Renato E. R. S. Santos
PBPallabi Basu
Pallabi Basu
BOBrendan J. O’HAra
Brendan J. O’HAra
JGJacob A. Gibson
Jacob A. Gibson
MGMichael J. Gebhardt
Michael J. Gebhardt
PWPaula I. Watnick
Paula I. Watnick
The cyclic AMP receptor protein or CRP is a global regulator of bacterial metabolism. CRP activates transcription of genes required for utilization of alternative carbon sources in response to the second messenger cAMP, which is synthesized in the setting of glucose scarcity. Transcription is activated through contact with RNA polymerase at three sites termed activating regions (ARs) 1-3. AR3 was previously reported to be functional only when CRP K52 was mutated to a neutral residue and to be essential for transcription only in the absence of AR1 and AR2. To probe the role of AR3 at the genome level, we used chromatin immunoprecipitation sequencing and RNA sequencing to compare WT CRP with a CRP K52Q mutant. This mutation resulted in hundreds of novel CRP chromosomal binding sites and differentially regulated transcripts including the small RNA CrbZ which represses acetate utilization. CrbZ was expressed by wild-type Vibrio cholerae only in cultures grown to stationary phase in maltose, and proteomic analysis of CRP isolated under these conditions demonstrated formylation of CRP K52. N ε -lysine formylation arises from a reaction with a high energy formylphosphate, which is a byproduct of oxidative DNA damage. Consistent with this, we find that CRP K52Q activates transcription of genes involved in the response to oxidative stress, DNA repair, and protein refolding as well as virulence and catabolism of specific carbon sources. We propose a model in which CRP K52 formylation signals oxidative DNA damage and alters the CRP regulon to protect the cell.